GUO LIANGQIN,HAGMANN WILLIAM K,HE SHUWEN,LAI ZHONG,LIU JIAN,NARGUND RAVI P,SHAH SHRENIK K,TRUONG QUANG T
申请号：
IN5966/DELNP/2012
公开号：
IN2012DN05966A
申请日:
2012.07.04
申请国别(地区):
IN
年份:
2013
代理人:
摘要：
Beta carboline derivatives of structural formula I are selective antagonists of the somatostatin subtype receptor 3 (SSTR3) and are useful for the treatment of Type 2 diabetes mellitus and of conditions that are often associated with this disease including hyperglycemia insulin resistance obesity lipid disorders and hypertension. The compounds are also useful for the treatment of depression and anxiety.
